USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
26-Aug-2024
Global
Market Research
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development.
According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040, which will fuel demand for tissue diagnostics. This increase highlights how urgently improved diagnostic tools are needed. The complexity of tissue diagnostics expanded due to advancements in cancer treatment, which require enhanced technology and capabilities in laboratories across the globe. Improving local diagnostic capacity is vital for managing the projected growth in cancer incidence worldwide, as it can improve test turnaround times and diagnostic accuracy—both of which substantially impact cancer treatment outcomes.
The pre-analytical staining market in the tissue diagnostics industry is being propelled by several key factors, such as growing advancements in staining technologies, pre-analytical platforms to simplify next-generation sequencing, automated staining platforms, and high-throughput systems to drive efficiency and reproducibility. Tissue diagnostics players are increasingly focusing on developing innovative and advanced systems and stains that enhance the specificity and sensitivity of tissue diagnostics. The advanced staining segment is the second leading segment due to a surge in adoption, especially driven by increased demand for ISH and IHC offerings, regulatory mandates to include CDx as part of pathology tests, and increased partnerships between biopharma companies and diagnostic companies.
Asia-Pacific’s growing cancer diagnostics infrastructure, increasing cancer prevalence rate, rising healthcare spending, increasing access to advanced diagnostic technologies, and growing government support all contribute to the region being the fastest-growing market.
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Tissue Diagnostic Industry
Scope of Analysis
Segmentation
Segmentation (continued)
Competitive Environment
Key Competitor by Technology
Growth Metrics
Growth Drivers
Growth Restraints
Trends in the Tissue Diagnostics Industry
Forecast Methodology and Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Revenue Forecast by Technology
Primary Growth Opportunities—Tissue Diagnostics Segments
Revenue Forecast by Region
Revenue Forecast Analysis by Region—NA
Tissue Diagnostics Market Dynamics—NA
Revenue Forecast Analysis by Region—Europe
Tissue Diagnostics Market Dynamics—Europe
Revenue Forecast Analysis by Region—APAC
Revenue Forecast Analysis by Region—APAC (continued)
Tissue Diagnostics Market Dynamics—APAC
Revenue Forecast Analysis by Region—MENASA & Latin America
Revenue Forecast by End User
Revenue Forecast Analysis by End User
Revenue Forecast Analysis by End User (continued)
Revenue Forecast Analysis by End User (continued)
Revenue Share
Revenue Share Analysis
Competitor Matrix
Competitor Matrix (continued)
Global Tissue Diagnostics Market—Notable Activities
Global Tissue Diagnostics Market—Notable Activities (continued)
Tissue Diagnostics Opportunity and Innovations Roadmap
Growth Metrics—Pre-Analytical Staining
Pre-analytical Staining Revenue Forecast
Pre-analytical Staining Revenue Forecast Analysis
Pre-analytical Staining Revenue Forecast Analysis (continued)
Pre-analytical Staining Revenue Forecast Analysis
Growth Metrics—Advance Staining
Advanced Staining Revenue Forecast
Advanced Staining—Revenue Forecast Analysis
Advanced Staining—Revenue Forecast Analysis (continued)
List of FDA-approved Tissue-based CDx, 2022–2023
List of FDA-approved Tissue-based CDx, 2022–2023 (continued)
List of FDA-approved Tissue-based CDx, 2022–2023 (continued)
Growth Metrics—ICP-APLIS
ICP-APLIS Revenue Forecast
ICP-APLIS—Revenue Forecast Analysis
ICP-APLIS—Revenue Forecast Analysis (continued)
ICP-APLIS—Revenue Forecast Analysis
Growth Opportunity 1—Comprehensive Diagnostic Panels for Early Identification Of Cancer Biomarkers
Growth Opportunity 1—Comprehensive Diagnostic Panels for Early Identification Of Cancer Biomarkers (continued)
Growth Opportunity 2—Multiomics Analysis for Precision Diagnostics
Growth Opportunity 2—Multiomics Analysis for Precision Diagnostics (continued)
Growth Opportunity 3—Digital Pathology Capabilities for Tissue-based Companion Diagnostics
Growth Opportunity 3—Digital Pathology Capabilities for Tissue-based Companion Diagnostics (continued)
Best Practices Recognition
Frost Radar
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
Legal Disclaimer
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Chandni Hussain |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | PFLA-01-00-00-00 |